Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tecovirimat

Tecovirimat (ST-246) is an orally bioavailable and selective compound against orthopoxviruses including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses. Tecovirimat is evaluated against vaccinia, cowpox virus, ectromelia virus with EC50 values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat targets the orthopoxvirus protein VP37 which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus[1][2][3][4][5].

Product Specifications

CAS Number

869572-92-9

Product Name Alternative

ST-246

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Arenavirus; Orthopoxvirus

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/tecovirimat.html

Purity

99.88

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(NN(C([C@]1([H])[C@@]2([H])[C@@](C3)([H])[C@@]3([H])[C@@](C=C2)([H])[C@]41[H])=O)C4=O)C5=CC=C(C(F)(F)F)C=C5

Molecular Formula

C19H15F3N2O3

Molecular Weight

376.33

Precautions

H302, H315, H319, H335

References & Citations

[1]Yang G, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J Virol. 2005 Oct;79 (20) :13139-49.|[2]Quenelle DC, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother. 2007 Feb;51 (2) :689-95.|[3]Andrew T Russo, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021 Mar;19 (3) :331-344.|[4]DeLaurentis CE, et al. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus[J]. Antimicrob Agents Chemother. 2022 Dec 20;66 (12) :e0122622. |[5]Almehmadi M, et al. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak[J]. Viruses. 2022 Aug 25;14 (9) :1870.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

NLE1 Antibody
8C17064-AAT 50 µg

NLE1 Antibody

Sign In for Pricing
View Details
DHRS4L2 Mouse Monoclonal Antibody [Clone ID: OTI4A10]
CF810277 100 µg

DHRS4L2 Mouse Monoclonal Antibody [Clone ID: OTI4A10]

Sign In for Pricing
View Details
Human LW1 (HSFX1) activation kit by CRISPRa
GA119296 1 Kit

Human LW1 (HSFX1) activation kit by CRISPRa

Sign In for Pricing
View Details
TRITC Conjugated Goat Polyclonal Antibody to Human Albumin
RA-2113-2 2 mL

TRITC Conjugated Goat Polyclonal Antibody to Human Albumin

Sign In for Pricing
View Details
NDRG4 (NM_001130487) Human Over-expression Lysate
LY427222 100 µg

NDRG4 (NM_001130487) Human Over-expression Lysate

Sign In for Pricing
View Details
LRRC26 (NM_001013653) Human Over-expression Lysate
LC423004 20 µg

LRRC26 (NM_001013653) Human Over-expression Lysate

Sign In for Pricing
View Details